Breast Cancer Research and Treatment

, Volume 39, Issue 3, pp 293–306 | Cite as

Structure-activity relations of s-adenosylmethionine decarboxylase inhibitors on the growth of MCF-7 breast cancer cells

  • Thresia Thomas
  • Carol A. Faaland
  • Sreedevi Adhikarakunnathu
  • T. J. Thomas
Report

Summary

SAMDC is a key enzyme in the biosynthesis of spermidine and spermine, 2 polyamines that are essential for cell proliferation. Inhibition of polyamine biosynthesis is often targeted as a therapeutic strategy to suppress cancer cell growth as these cells contain elevated levels of polyamines. We examined the effect of a new group of SAMDC inhibitors, CGP33829, CGP35753, CGP36958, CGP39937, and CGP48664, (obtained from CibaGeigy, Basel, Switzerland), and their parent compound, MGBG, on the proliferation of MCF-7 breast cancer cells. MGBG had minimal effects on the proliferation of MCF-7 cells up to 6 µM concentration. In contrast, CGP48664 and CGP39937, containing 2 aromatic rings that delocalize the π electron system of the backbone of MGBG, were potent inhibitors with 50% growth inhibition at 0.5 µM concentration. Other CGP compounds were less effective in inhibiting cell growth. The ability of CGP48664 to inhibit MCF-7 cell proliferation was related to its ability to inhibit SAMDC and to consequently deplete spermidine and spermine levels in the cell. Exogenous spermidine and spermine could reverse the growth inhibitory effects of this compound. CGP compounds also increased the activity of ODC, another enzyme involved in polyamine biosynthesis. Northern blot analysis of mRNA from MCF-7 cells progressing in cell cycle after G1 synchronization did not show an increase in ODC mRNA level by CGP48664. These data demonstrate structure-activity relationships of a series of MGBG derivatives on cell growth, enzyme activities, and polyamine biosynthesis in a hormoneresponsive breast cancer cell line and suggest potential application of SAMDC inhibitors as therapeutic agents.

Key words

polyamines MCF-7 cells ODC SAMDC enzyme inhibitors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tabor CW, Tabor H: Polyamines. Annu Rev Biochem 53: 749–790, 1984PubMedGoogle Scholar
  2. 2.
    Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759–774, 1988PubMedGoogle Scholar
  3. 3.
    Heby O, Persson L: Regulation of polyamine biosynthesis in eukaryotic cells. Trends Biochem Sci 15: 153–158, 1988Google Scholar
  4. 4.
    McCann PP, Pegg AE, Sjoerdsma A (eds): Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies. Academic Press, New York, 1987Google Scholar
  5. 5.
    Shappell NW, Fogel-Petrovic MF, Porter CW: Regulation of spermidine/spermineN 1-acetyltransferase by intracellular polyamine pools. FEBS Lett 321: 179–183, 1993PubMedGoogle Scholar
  6. 6.
    Scalabrino G, Ferioli ME: Polyamines in mammalian tumors. Adv Cancer Res 35: 151–267, 1981PubMedGoogle Scholar
  7. 7.
    Chanda R, Ganguly AK: Polyamines in relation to human breast, rectal, and squamous cell carcinoma. Cancer Lett 39: 311–318, 1988PubMedGoogle Scholar
  8. 8.
    Kingsnorth AN, Wallace HM, Bundred NJ: Polyamines in breast cancer. Br J Surg 71: 352–356, 1984PubMedGoogle Scholar
  9. 9.
    Cohen S, O'Malley BW, Stastny M: Estrogenic induction of ornithine decarboxylasein vivo andin vitro. Science 170: 336–338, 1970PubMedGoogle Scholar
  10. 10.
    Thomas T, Thomas TJ: Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: Therapeutic implications. Breast Cancer Res Treat 29: 189–201, 1993Google Scholar
  11. 11.
    Williams-Ashman HG, Schenone A: Methyl glyoxal (bisguanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylase. Biochem Biophys Res Commun 46: 288–295, 1972PubMedGoogle Scholar
  12. 12.
    Metcalf BW, Bey P, Danzin C, Jung MJ, Casara P, Vevett JP: Catalytic irreversible inhibition of mammalian ornithine decarboxylase. J Amer Chem Soc 100: 2551–2553, 1978Google Scholar
  13. 13.
    Pegg AE: In: Bachrach U, Heimer YM (eds) The Physiology of Polyamines pp 303–314. CRC Press Boca Raton, FL, 1989Google Scholar
  14. 14.
    Abeloff MD, Rosen ST, Luk GD, Baylin SB, Zeltzman M, Sjoerdsma A: Phase II trials of α-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small lung cancer and colon cancer. Cancer Treat Rep 70: 843–845, 1986PubMedGoogle Scholar
  15. 15.
    Warrell RP Jr, Burchenal H: Methylglyoxal-bis(guanylhydrazone) (methyl GAG): current status and future prospects. J Clin Oncol 1: 52–65, 1983PubMedGoogle Scholar
  16. 16.
    Pegg AE, McCann PP: S-adenosylmethionine decarboxylase as an enzyme target for therapy. Pharmac Ther 56: 359–377, 1992Google Scholar
  17. 17.
    Stanek J, Caravatti G, Capraro HG, Furet P, Mett H, Schneider P, Matter A, Regenass U: S-adenosylmethionine decarboxylase inhibitors: New aryl and heteroaryl analogues of methylglyoxal bis(guanylhydrazone). J Med Chem 36: 46–54, 1993PubMedGoogle Scholar
  18. 18.
    Basu HS, Feuerstein BG, Deen DF, Lubich WP, Bergeron RJ, Samejima K, Marton LJ: Correlation between the effects of polyamine analogs on DNA conformation and cell growth. Cancer Res 49: 5591–5597, 1989PubMedGoogle Scholar
  19. 19.
    Thomas T, Kiang DT: Additive growth-inhibitory effects of difluoromethylornithine and antiestrogens on MCF-7 cell line. Biochem Biophys Res Commun 148: 1338–1345, 1987PubMedGoogle Scholar
  20. 20.
    Thomas T, Trend B, Butterfield JB, Jänne OA, Kiang DT: Regulation of ornithine decarboxylase gene expression in MCF-7 breast cancer cells by antiestrogens. Cancer Res 49: 5852–5857, 1989PubMedGoogle Scholar
  21. 21.
    Manni A: Polyamines and hormonal control of breast cancer cell growth. CRC Critical Rev Oncogenesis 1: 163–174, 1989Google Scholar
  22. 22.
    Thomas T, Kiang DT: Structural alterations and stabilization of rabbit uterine estrogen receptors by natural polyamines. Cancer Res 47: 1799–1804, 1987PubMedGoogle Scholar
  23. 23.
    Thomas T, Kiang DT: A twenty two-fold increase in the relative binding affinity of estrogen receptor to poly(dA-dC) poly(dG-dT) in the presence of polyamines. Nucleic Acids Res 16: 4705–4720, 1988PubMedGoogle Scholar
  24. 24.
    Thomas T, Thomas TJ: Structural specificity of polyamines in modulating the binding of estrogen receptor to potential Z-DNA forming sequences. J Receptor Res 13: 1115–1133, 1993Google Scholar
  25. 25.
    Thomas T, Gallo MA, Klinge CM, Thomas TJ: Polyamineinduced conformational perturbations in DNA alter the binding of estrogen receptor to poly(dG-m5dC).poly(dG-m5dC) and a plasmid containing estrogen response element. J Steroid Biochem Mol Biol 54: 89–99, 1995PubMedGoogle Scholar
  26. 26.
    Beato M: Transcriptional control by nuclear receptors. FASEB J 5: 2044–2051, 1991PubMedGoogle Scholar
  27. 27.
    O'Malley BW: The steroid receptor superfamily: More excitement predicted for the future. Mol Endocrinol 4: 363–369, 1990PubMedGoogle Scholar
  28. 28.
    Regenass U, Caravatti G, Mett H, Stanek J, Schneider P, Müller M, Matter A, Vertino P, Porter CW: NewS-adenosylmethionine decarboxylase inhibitors with potent antitumor activity. Cancer Res 52: 4712–4718, 1992PubMedGoogle Scholar
  29. 29.
    Berthois Y, Katzenellenbogen JA, Katzenellenbogan BS: Phenol red in tissue culture media is a weak estrogen; implication concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496–2500, 1986PubMedGoogle Scholar
  30. 30.
    Burton K: A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315–323, 1956PubMedGoogle Scholar
  31. 31.
    Shantz LM, Holm I, Jänne OA, Pegg AE: Regulation ofS-adenosylmethionine decarboxylase activity by alterations in the intracellular polyamine content. Biochem J 288: 511–518, 1992PubMedGoogle Scholar
  32. 32.
    Matsui I, Pegg AE: Effect of thioacetamide, growth hormone or partial hepatectomy on spermidine acetylase activity of rat liver cytosol. Biochem Biophys Res Commun 92: 1009–1015, 1980PubMedGoogle Scholar
  33. 33.
    Casero RA, Mank AR, Xiao L, Smith J, Bergeron RJ, Celano P: Steady-state mRNA and activity correlates with sensitivity of N1,N12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res 52: 5359–5363, 1992PubMedGoogle Scholar
  34. 34.
    Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976PubMedGoogle Scholar
  35. 35.
    Thomas T, Thomas TJ: Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res 54: 1077–1084, 1994PubMedGoogle Scholar
  36. 36.
    Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, pp 202–203, 1982Google Scholar
  37. 37.
    Lau CF, Sheu SS: Rapid and direct recovery of DNA fragments from agarose gels; an extremely simple method. Methods Mol Cell Biol 3: 190–192, 1992Google Scholar
  38. 38.
    Pajunen A, Crozat A, Jänne OA, Ihalainen R, Laitinen P, Stanley B, Madhubala R, Pegg AE: Structure and regulation of mammalianS-adenosylmethionine decarboxylase. J Biol Chem 32: 17040–17049, 1988Google Scholar
  39. 39.
    Casero RA Jr, Celano P, Ervin SJ, Applegren NB, Wiest L, Pegg AE: Isolation and characterization of a cDNA clone that codes for human spermidine/spermineN 1acetyltransferase. J Biol Chem 266: 810–814, 1991PubMedGoogle Scholar
  40. 40.
    Pegg AE, Erwin BG, Persson EL: Induction of spermidine and spermine N1acetyl transferase by methylglyoxal bis(guanylhydrazone). Biochem Biophys Acta 842: 111–118, 1985PubMedGoogle Scholar
  41. 41.
    Davidson NE, Mank A, Prestigiacomo LJ, Bergeron RJ, Casero RA: Growth inhibition of hormone-responsive and resistant human breast cancer cells in culture by N1,N12bis (ethyl)spermine. Cancer Res 53: 2071–2075, 1993PubMedGoogle Scholar
  42. 42.
    Lapinjoki SP, Gynther J: Contribution of p-electrons to the inhibition of S-adenosylmethionine decarboxylase by aromatic tricyclic compounds. Biochem Int 12: 847–853, 1986PubMedGoogle Scholar
  43. 43.
    Regenass U, Mett H, Stanek J, Müeller M, Kramer D, Porter CW: CGP48664, a newS-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Cancer Res 54: 3210–3217, 1994PubMedGoogle Scholar
  44. 44.
    Persson L, Holm I, Heby O: Regulation of ornithine decarboxylase mRNA translation by polyamines. J Biol Chem 263: 3528–3533, 1988PubMedGoogle Scholar
  45. 45.
    Pegg AE, Jones DB, Secrist JA III: Effects of S-adenosylmethionine decarboxylase on polyamine content and growth of L1210 cells. Biochemistry 27: 1408–1415, 1989Google Scholar
  46. 46.
    Casara P, Marchal P, Wagner J, Danzin C: 5′-[(Z)-4-amino-2-butenyl]methylamino]-5′deoxyadenosine: a potent enzyme activated irreversible inhibitor of S- adenosylmethionine decarboxylase from E.coli. J Amer Chem Soc 111: 9111–9113, 1989Google Scholar
  47. 47.
    Wu Y, Woster PM: S-(5′deoxy-5′-adenosyl)-1-amino-4-methylthio-2-cyclopentene (adoMac): a potent enzyme activated irreversible inhibitor of S-adenosylmethionine decarboxylase. J Med Chem 35: 3196–3201, 1992PubMedGoogle Scholar
  48. 48.
    Igarashi K, Porter CW, Morris DR: Comparison of specificity of polyamine synthesis in bovine lymphocytes by ethylglyoxal bis(guanylhydrazone) and methylglyoxal bis(guanylhydrazone). Cancer Res 44: 5326–5331, 1984PubMedGoogle Scholar
  49. 49.
    Elo H, Mutikainen I, Alhone-Hongisto L, Laine R, Jänne J: Diethylglyoxal bis(guanylhydrazone)sulfate — a novel highly potent inhibitor of S-adenosylmethionine decarboxylase with promising properties for potential chemotherapeutic use. Cancer Lett 41: 21–30, 1988PubMedGoogle Scholar
  50. 50.
    Tsukada T: Antitumor effects of methylglyoxal-guanylhydrazone-cyclopentylamidinohydrazone. Mie Med J 36: 157–168, 1986Google Scholar
  51. 51.
    Porter CW, Sulfrin JR: Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as potential anticancer chemotherapeutic strategy: a review. Anticancer Res 6: 525–542, 1986PubMedGoogle Scholar
  52. 52.
    Basu HS, Feuerstein BG, Deen DF, Lubich WP, Bergeron RJ, Aamejima K, Marton LJ: Correlation between effects of polyamine analogs on DNA conformation and growth. Cancer Res 49: 5591–5597, 1989PubMedGoogle Scholar
  53. 53.
    Porter C: Polyamine inhibitors and analogs as potential anticancer agents. In: Dowling RH, Folsch UR, Loser Chr (eds) Polyamines in the Gastrointestinal Tract, Falk Symposium 62. Kluwer Academic Publishers, Dordrecht, 1992, pp 301–322Google Scholar
  54. 54.
    Thomas T, Kiang DT, Jänne OA, Thomas TJ: Variations in amplification and expression of the ornithine decarboxylase gene in breast cancer cell lines. Breast Cancer Res Treat 19: 257–267, 1991PubMedGoogle Scholar
  55. 55.
    Lima G, Shiu RPC: Role of polyamines in estradiol-induced growth of human breast cancer cells. Cancer Res 45: 2466–2470, 1985PubMedGoogle Scholar
  56. 56.
    Cohen FJ, Manni A, Glikman P, Bartholomew M, Demers L: Involvement of the polyamine pathway in antiestrogeninduced growth inhibition of human breast cancer. Cancer Res 48: 6819–6825, 1988PubMedGoogle Scholar
  57. 57.
    Norman JC, Puddefoot JR, Anderson E, Braunsberg H: Relationships between polyamine, deoxyribonucleic acid, and estrogen receptor binding site concentrations in human breast tumors. Eur J Cancer Clin Oncol 24: 603–613, 1988PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Thresia Thomas
    • 1
  • Carol A. Faaland
    • 1
  • Sreedevi Adhikarakunnathu
    • 1
  • T. J. Thomas
    • 2
  1. 1.Department of Environmental & Community Medicine, Environmental and Occupational Health Sciences InstituteUniversity of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical SchoolNew BrunswickUSA
  2. 2.Department of MedicineUniversity of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical SchoolNew BrunswickUSA

Personalised recommendations